| Schedule of Condensed Financial Statements |
| | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2025 | | 2024 | | 2023 | | (in thousands) | | Intercompany revenue | $ | — | | | $ | 148 | | | $ | 226 | | | Selling, general, and administrative expenses | 11,737 | | | 13,803 | | | 10,812 | | | Total operating expenses | 11,737 | | | 13,803 | | | 10,812 | | | Loss from operations | (11,737) | | | (13,655) | | | (10,586) | | | Interest expense, net | 103 | | | (387) | | | (321) | | | Tax receivable agreement liability adjustment | 427 | | | (547) | | | 100,223 | | | Equity in net loss of subsidiaries | (56,153) | | | (186) | | | (114,697) | | | Loss before income taxes | (67,360) | | | (14,775) | | | (25,381) | | | Income tax (benefit) expense | — | | | (57) | | | 128,698 | | | Net loss | $ | (67,360) | | | $ | (14,718) | | | $ | (154,079) | |
| | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2025 | | 2024 | | 2023 | | (in thousands) | | Net loss | $ | (67,360) | | | $ | (14,718) | | | $ | (154,079) | | | Other comprehensive income (loss): | | | | | | Foreign currency translation (loss) gain, net of tax effect of $0, $0 and $(770) for the years ended December 31, 2025, 2024 and 2023, respectively | 6,297 | | | (1,496) | | | 2,423 | | | | | | | | Comprehensive loss attributable to Funko, Inc. | $ | (61,063) | | | $ | (16,214) | | | $ | (151,656) | |
| | | | | | | | | | | | | December 31, | | 2025 | | 2024 | | (in thousands, except per share data) | | Assets | | | | | Current assets: | | | | | Cash and cash equivalents | $ | 3,486 | | | $ | 1,258 | | | Income tax receivable | 202 | | | 202 | | | Total current assets | 3,688 | | | 1,460 | | | | | | | Intercompany receivable | 110,887 | | | 113,009 | | | | | | | Investment in subsidiaries | 71,359 | | | 119,097 | | | Total assets | $ | 185,934 | | | $ | 233,566 | | | Liabilities and Stockholders' Equity | | | | | Current liabilities: | | | | | | | | | Current portion of liabilities under tax receivable agreement | $ | 120 | | | $ | 547 | | | | | | | Total current liabilities | 120 | | | 547 | | | | | | | | | | | | | | | | | | | Commitments and contingencies | | | | | | | | | Stockholders' equity: | | | | Class A common stock, par value $0.0001 per share, 200,000 shares authorized; 55,327 shares and 52,967 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 5 | | | 5 | | Class B common stock, par value $0.0001 per share, 50,000 shares authorized; 91 shares and 1,430 shares issued and outstanding as of December 31, 2025 and 2024, respectively | — | | | — | | | Additional paid-in-capital | 357,330 | | | 343,472 | | | Accumulated other comprehensive income (loss) | 4,621 | | | (1,676) | | | Accumulated deficit | (176,142) | | | (108,782) | | | Total stockholders' equity | 185,814 | | | 233,019 | | | Total liabilities and stockholders' equity | $ | 185,934 | | | $ | 233,566 | |
| | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2025 | | 2024 | | 2023 | | | | | | | | (in thousands) | | Operating Activities | | | | | | | Net loss | $ | (67,360) | | | $ | (14,718) | | | $ | (154,079) | | Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | | | | | | | Equity in net loss of subsidiaries | 56,153 | | | 186 | | | 114,697 | | | Equity-based compensation | 11,536 | | | 13,602 | | | 10,534 | | | Deferred tax (benefit) expense | — | | | (57) | | | 123,124 | | | Tax receivable liability adjustment | (427) | | | 547 | | | (100,223) | | | Changes in operating assets and liabilities, net of amounts acquired: | | | | | | | Income tax receivable | — | | | 110 | | | 7,219 | | | Due from related parties, net | 2,121 | | | 5,778 | | | 436 | | | | | | | | | | | | | | | Accrued expenses and other liabilities | — | | | (374) | | | 370 | | | Net cash provided by operating activities | 2,023 | | | 5,074 | | | 2,078 | | | | | | | | | Investing Activities | | | | | | | | | | | | | Net cash used in investing activities | — | | | — | | | — | | | | | | | | | Financing Activities | | | | | | | | | | | | | Tax receivable agreement payments | — | | | (8,960) | | | (4) | | | Proceeds from exercise of equity-based options | 227 | | | 1,410 | | | 749 | | | Other | (22) | | | — | | | — | | | Net cash provided by (used in) financing activities | 205 | | | (7,550) | | | 745 | | | | | | | | | Net change in cash and cash equivalents | 2,228 | | | (2,476) | | | 2,823 | | | Cash and cash equivalents at beginning of period | 1,258 | | | 3,734 | | | 911 | | | Cash and cash equivalents at end of period | $ | 3,486 | | | $ | 1,258 | | | $ | 3,734 | | | | | | | | | Supplemental Cash Flow Information | | | | | | | | | | | | | Establishment of liabilities under tax receivable agreement | — | | | 547 | | | — | | | | | | | |
|